Aptose Biosciences is based out of Toronto. Lorus Therapeutics is a biopharmaceutical company. Co. is engaged in the discovery, research and development of novel anticancer therapies with a safety profile. Co. has worked to establish a marketable anticancer product pipeline, with products in various stages of development ranging from discovery and pre-clinical to preparation for initiation of a Phase III clinical trial. Co. is considered to be in the development stage. The firm last filed a Form D notice of exempt offering of securities on 2014-04-24. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Aptose Biosciences Inc.251 CONSUMERS ROAD
TORONTO A6 M2J 4R3
Business Phone: 647-479-9828
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)